Belgian pharmaceuticals giant Solvay posts profit rise

Belgium's pharmaceuticals giant Solvay announced a better-than-expected 6.0 percent rise in net profit for the second quarter on Friday, sending its shares rising sharply.

Shortly after the opening of trade in Brussels, shares in Solvay showed a 6.94 percent rise to 87.12 euros after the announcement of the results, which show the company on track to do as well in 2012 as the previous year.

Solvay said that despite the in demand in the sector in June, cuts and restructuring would enable it to do as well as in 2011.

The group reported adjusted of 244 million euros from April to June.

add to favorites email to friend print save as pdf

Related Stories

Wind turbine maker's shares plunge 19%

Jan 04, 2012

Vestas, the world leader in the wind turbine industry, saw its share price plummet around 19 percent at the opening Wednesday, a day after issuing a profit warning.

Amadeus posts 2011 profit of 453.7 bn euros

Feb 24, 2012

The Spanish group Amadeus, a world leading technology provider for the travel and tourism industries, posted on Friday a jump of 657 percent in 2011 net profit, owing to one-off effects.

SAP says profits up in first quarter

Apr 25, 2012

German software giant SAP said Wednesday it was sticking to its full-year targets for 2012 after net profit rose 10 percent in the first three months.

Recommended for you

Were clinical trial practices in East Germany questionable?

11 hours ago

Clinical trials carried out in the former East Germany in the second half of the 20th century were not always with the full knowledge or understanding of participants with some questionable practices taking place, according ...

Schumacher's doctor sees progress after injury

Oct 23, 2014

A French physician who treated Michael Schumacher for nearly six months after the Formula One champion struck his head in a ski accident says he is no longer in a coma and predicted a possible recovery within three years.

User comments